EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A pH-Responsive DNA Tetrahedron/Methotrexate Drug Delivery System Used for Rheumatoid Arthritis Treatment

Yi Jin, Xingyu Ge, Yinjin Xu, Siyi Wang, Qian Lu, Aidong Deng, Jingjing Li, Zhifeng Gu

Journal of Functional Biomaterials · 03.11.2023 · 14 (11) · 541

DOI: 10.3390/jfb14110541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 03.11.2023. Verfasst von Yi Jin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226000, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science and Technology Project of Nantong City, Graduate Research and Innovation Projects of Jiangsu Province, Postdoctoral Research Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that leads to progressive and aggressive joint inflammation. The disease process is characterized by the activation of macrophages, which then release tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), accelerating tissue damage. Tackling tissue damage is a crucial target in the treatment of RA. In this study, a macrophage-targeted and pH-response DNA tetrahedron/methotrexate drug delivery system was constructed by loading methotrexate (MTX) onto a DNA duplex. MTX was used as a drug model, and a pH-response DNA tetrahedron (TET) was used as the drug carrier, which was modified with hyaluronic acid (HA) to target macrophages. The aim of this study was to evaluate the potential of TET as an effective drug carrier for the treatment of RA. On this basis, we successfully prepared TETs loaded with MTX, and in vitro assays showed that the MTX-TET treatment could successfully target macrophages and induce macrophages to polarize to M1 phenotype. At the same time, we also injected MTX-TET intravenously into collagen-induced arthritis (CIA) model mice, and the redness and swelling of the paws of mice were significantly alleviated, proving that the MTX-TET could successfully target inflamed joints and release MTX to treat joint swelling. In addition, the histochemical results showed that the MTX-TET could reduce synovitis and joint swelling in CIA mice, reduce the level of inflammatory factors in vivo, and improve the disease status while maintaining a good biosafety profile. This study showed that the MTX-TET treatment has beneficial therapeutic effects on RA, providing a new strategy for the clinical treatment of RA.

Schlagwörter

Stichwörter der Autor:innen

DNA tetrahedronRheumatoid arthritismacrophagemethotrexate

Autor:innen und Institutionen

  • Department of Rheumatology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226000, China.
  • Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226000, China.
  • Department of Rheumatology, Yancheng Third People's Hospital, Yancheng 224000, China.
  • Department of Hand Surgery, Affiliated Hospital of Nantong University, Nantong 226000, China.

Förderung

  • the Science and Technology Project of Nantong City
  • Graduate Research and Innovation Projects of Jiangsu Province
  • Postdoctoral Research Foundation of China
  • National Natural Science Foundation of China
  • Science and Technology Project of Nantong City
  • Postgraduate Research and Practice Innovation Program of Jiangsu Province
  • Jiangsu Provincial Medical Key Discipline Cultivation Unit
  • Jiangsu Provincial Research Hospital

Zitieren

APA

Jin, Y., Ge, X., Xu, Y., Wang, S., Lu, Q., Deng, A., Li, J., & Gu, Z. (2023). A pH-Responsive DNA Tetrahedron/Methotrexate Drug Delivery System Used for Rheumatoid Arthritis Treatment. Journal of Functional Biomaterials, 14(11), 541. https://doi.org/10.3390/jfb14110541

Vancouver

Jin Y, Ge X, Xu Y, Wang S, Lu Q, Deng A, et al. A pH-Responsive DNA Tetrahedron/Methotrexate Drug Delivery System Used for Rheumatoid Arthritis Treatment. Journal of Functional Biomaterials. 2023;14(11):541. doi:10.3390/jfb14110541

BibTeX
@article{Jin2023,
  author = {Jin, Yi and Ge, Xingyu and Xu, Yinjin and Wang, Siyi and Lu, Qian and Deng, Aidong and Li, Jingjing and Gu, Zhifeng},
  title = {A pH-Responsive DNA Tetrahedron/Methotrexate Drug Delivery System Used for Rheumatoid Arthritis Treatment},
  journal = {Journal of Functional Biomaterials},
  year = {2023},
  volume = {14},
  number = {11},
  pages = {541},
  doi = {10.3390/jfb14110541}
}
Kostenlos starten →